Polymorphism in the tumor necrosis factor-α promotor region and in the heat shock protein 70 genes associated with malignant tumors

Cancer

Volumn 80, Issue 8, 1997, Pages 1489-1496

  Chouchane, Lotfi ^a   Ahmed, Slim Ben ^b   Baccouche, Sami ^d   Remadi, Sami ^c  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d Fac Médecine de Monastir ^*

Author keywords

Cancer; Heat shock proteins; Polymorphism; Tumor necrosis factor

Indexed keywords

HEAT SHOCK PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; BREAST CARCINOMA; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; TUNISIA;

ADULT; ALLELES; BREAST NEOPLASMS; DNA; DNA, NEOPLASM; FEMALE; GASTROINTESTINAL NEOPLASMS; HAPLOTYPES; HOMOZYGOTE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030763626     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO;2-1     Document Type: Article

References (42)

1. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975;2:3666-70.
2. Beutler B, Cerami A. The biology of cachectin/TNF: a primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
3. Jäätelä M. Biological activities and mechanisms of action of tumor necrosis factor alpha/cachectin. Lab Invest 1991;64:724-42.
4. Gadducci A, Ferdeghini M, Castellani C, Annicchiarico C, Gagetti O, Prontera C, et al. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55-and 75 kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer. Gynecol Oncol 1995;58:184-8.
5. Partanen R, Koskinen H, Hemminki K. Tumor necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer. Occup Environ Med 1995;52:316-9.
6. Himeno T, Watanabe N, Yamauchi N, Maeda M, Tsuji Y, Okamoto T, et al. Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res 1990;50:4941-5.
7. Okamoto T, Watanabe N, Yamauchi N, Tsuji N, Itoh Y, Neda H, et al. Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res 1992;52:5278-81.
8. Tsuji Y, Watanabe N, Okamoto T, Tsuji N, Sasaki H, Akiyama S, et al. Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity. Cancer Res 1992;52:6258-62.
9. Fujiki H, Komori A, Yatsunami J. Tumor necrosis factor as an endogenous tumor promotor. Proc Am Assoc Cancer Res 1993;34:180.
10. Fujiki H, Suganuma M, Komori A, Yatsunami J, Okabe S, Ohta T, et al. A new tumor promotion pathway and its inhibitors. Cancer Detect Prev 1994;18:1-7.
11. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNFα) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1993;1:353-9.
12. Wilson AG, Symons JA, Mc Dowell TL, di Giovine FS, Duff GW. Effects of a tumor necrosis factor (TNF-alpha) promotor base transition on transcriptional activity. Br J Rheumatol 1994;33:89-97.
13. Sargent CA, Dunham I, Trowsdale J, Campbell RD. Human major histocompatibility complex contains genes for the major heat shock protein HSP70. Proc Natl Acad Sci U S A 1989;86:1968-72.
14. Milner CM, Campbell RD. Structure and expression of the MHC-linked HSP70 genes. Immunogenetics 1990;32:242-51.
15. Hunt C, Morimoto RI. Conserved features of eukaryotic HSP70 genes revealed by comparison with the nucleotide sequence of human HSP70. Proc Natl Acad Sci U S A 1985;82:6455-9.
16. Cai JW, Hughe CS, Shen JW, Subjeck JR. Induction of heat shock proteins by glutamine: the "feeding effect." FEBS Lett 1991;288:229-32.
17. Beckmann RP, Lovett M, Welch JW. Examining the function and regulation of HSP70 in cells subjected to metabolic stress. J Cell Biol 1992;117:1137-50.
18. Nakamura K, Rokutan K, Marni N. Induction of heat shock proteins and their implication in protection against ethanol-induced damage in cultured guinera pic gastric mucosal cells. Gastroenterology 1991;101:161-9.
19. Van Buskirk AM, De Nagel DC, Gualiardi LE. Cellular and subcellular distribution of PBP 72/74, a peptide-binding proteins that plays a role in antigen processing. J Immunol 1991;146:500-6.
20. Young RA. Stress proteins and immunology. Annu Rev Immunol 1990;8:401-20.
21. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned-peptides. Science 1995;269:1585-8.
22. Davidoff AM, Iglehart DI, Marks JR. Immune response to p53 is dependent upon p 53/HSP70 complexes in breast cancer. Proc Natl Acad Sci U S A 1992;89:3439-42.
23. Schiaffonati L, Pappalardo C, Tacchini L. Expression of the HSP70 gene family in rat hepatoma cell lines of different growth rates. Exp Cell Res 1991;196:330-6.
24. Gress TM, Muller-Pillasch F, Weber C. Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res 1994;54:547-51.
25. Ciocca DR, Clark GM, Tandon AK. Heat shock protein HSP70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 1993;85:570-4.
26. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
27. Wu Dy, Ugozolli L, Pal BK, Wallace B. Allele-specific enzymatic amplification of β-globulin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci U S A 1989;86:2757-60.
28. Verjans GM GM, Brinkman BNM, Van Doornik CEM, Kijlstra A, Verweij CL. Polymorphism of tumor necrosis factor-alpha (TNF-α) at position-308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994;97:45-7.
29. Milner CM, Campbell RD. Polymorphic analysis of the three MHC-linked HSP70 genes. Immunogenetics 1992;36:357-62.
30. Dyer P, Warrens A. Design and interpretation of studies of the major histocompatibility complex in disease. In: Lechler R, editor. HLA and disease. London. Academic Press, 1994:93-121.
31. Kleinbaum N, Kupper S, Morgensten N. Principles and quantitative methods. In: Epidemiologic research. London: Lifetime Learning Publications, 1982.
32. Ott J. Analysis of human genetic linkage. Baltimore: The Johns Hopkins University Press, 1991:245-6.
33. Mc Guire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkwski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
34. Terasaki PI, Perdue ST, Mickey MR. HLA frequencies in cancer: a second study. In: Mulvihill JJ, Miller RW, Fraumeni JF, editors. Genetics of human cancer. New York: Raven Press, 1977:321-8.
35. Markman M, Braine HG, Abeloff MD. Histocompatibility antigens in small cell carcinoma of the lung. Cancer 1984;54:2943-5.
36. Prazak J, Mericka O. HLA and bronchogenic carcinoma. Neoplasma 1989;36:599-602.
37. Romano PJ, Bartholomew M, Smith PJ, Kloszewski F, Stryker J, Houk J, et al. HLA antigens influence resistance to lung carcinoma. Hum Immunol 1991;31:236-240.
38. Rippmann F, Taylor WR, Rothbard JB, Green NM. A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA. EMBO J 1991;10:1053-9.
39. Jäättelä M, Wissing D. Heat shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self protection. J Exp Med 1993;177:231-6.
40. Jäättelä M. Overexpression of major heat shock protein HSP70 inhibits tumor necrosis factor-induced activation of phospholipase A2. J Immunol 1993;151:4286-94.
41. Tauchi K, Tsutsumi Y, Yoshimura S. Expression of heat shock protein 70 and C-myc protein in human breast cancer: an immunhistochemical study. Jpn J Clin Oncol 1991;21:256-63.
42. Lehman TA, Bennett WP, Metcalf RA. p 53 mutation, ras mutation and p 53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 1991;51:4090-6.